News

October 11, 2016October 11, 2016

Immunosuppressive Agents Combined with Stelara Could Control Psoriasis, Study Finds

News

The addition of an immunosuppressive agent to Stelara (ustekinumab) could restore the response to treatment in psoriasis patients according to a study titled “Recapturing adequate control of psoriasis by additional ... Read more

October 6, 2016October 6, 2016

Potential Plaque Psoriasis Treatment, Guselkumab, Shows Effectiveness in Phase 3 Study

News

Janssen Research & Development announced that guselkumab demonstrated positive results in the Phase 3 VOYAGE 1 study investigating its effectiveness and safety in patients with moderate-to-severe plaque psoriasis. According to a recent Janssen press ... Read more

October 4, 2016October 4, 2016

New Data Supports Effectiveness of Cosentyx to Treat Psoriasis Over 4 Years

News

Novartis has released late-breaking data from an extension study of two Phase 3 clinical trials evaluating Cosentyx (secukinumab) to treat moderate-to-severe plaque psoriasis. The data supported the efficacy of the treatment in the long-term, ... Read more

September 29, 2016

FDA Approves Amjevita as Humira Biosimilar to Treat Psoriasis and Other Inflammatory Diseases

News

The U.S. Food and Drug Administration (FDA) has approved Amgen’s Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab, AbbVie) for use in multiple inflammatory diseases, including psoriasis. Amjevita is now approved ... Read more

September 27, 2016

Psoriasis and Depression Seen to Be ‘Linked’ by Inflammatory Mechanisms in Study

News

There is a significant link between psoriasis and depression according to a study published in the scientific journal Skin Pharmacology and Physiology.

September 22, 2016

Inaugural Psoriatic Arthritis Awareness Day Stresses Early Diagnosis, Treatment

News

Celgene Corporation and the National Psoriasis Foundation (NPF) have joined efforts to designate Sept. 28 as the inaugural Psoriatic Arthritis Awareness Day, a day dedicated to spreading the word about ... Read more

September 20, 2016

Treating Psoriatic Dactylitis with TNF-Alpha Inhibitors Like Remicade Improves Symptoms, Report Shows

News

New research suggests that symptoms of psoriatic dactylitis, a manifestation of psoriatic arthritis (PsA), can be improved with therapies that promote the inhibition of TNF-alpha, one of the most important molecular players ... Read more

September 15, 2016

Can-Fite’s Patent Application for Psoriasis Therapy Candidate Accepted in Europe

News

Can-Fite BioPharma has received a notice of allowance from the European Patent Office (EPO) accepting the patent application for the company’s new psoriasis treatment Piclidenoson (CF101). Piclidenoson is a novel adenosine ... Read more

September 13, 2016

Psoriatic Arthritis Patients’ Symptoms Improved with Otezla Treatments

News

Results from a Phase III clinical trial showed that treatment with Otezla (apremilast) led to clinical improvements in patients with psoriatic arthritis for up to 13 months, including signs and symptoms, ... Read more

September 8, 2016September 8, 2016

Vigorous Regular Exercise Can Lower Risk of Psoriasis, Study Finds

News

The importance of exercise has been emphasized in recent years, as researchers find more and more evidence that physical activity helps to prevent illness and improve general health. These benefits appear to extend to ... Read more